2 exciting ETFs named as buys by experts

If you’re wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here’s what they are saying about them:

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you’re wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren’t keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what’s the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that’s where you want to be invested over the next couple of decades.

The post 2 exciting ETFs named as buys by experts appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Experts say these top ETFs are buys right now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/rZ1ufyO